Business
Envoy Medical Announces Proposed Board Slate of Experienced Medical Device and Financial Leaders
Board Reflects Expanded Resources as Company Readies for Nasdaq Listing White Bear Lake, Minnesota--(Newsfile Corp. - September 19, 2023) - Envoy Medical®
About this update from Envoy Medical, Inc.
[{"type":"text","content":"Board Reflects Expanded Resources as Company Readies for Nasdaq Listing\nWhite Bear Lake, Minnesota--(Newsfile Corp. - September 19, 2023) - Envoy Medical® Corporation (\"Envoy\"), a hearing health company, today announced the proposed slate of seven directors to be voted on during the special meeting of stockholders to be held by its merger partner, Anzu Special Acquisition Corp (NASDAQ: ANZU) (NASDAQ: ANZUU) (NASDAQ: ANZUW) (\"Anzu\"), which is expected to be held on September 27, 2023. The director nominees bring medical device industry, financial and equity capital markets expertise, including alumni of Abbott, Medtronic, Boston Scientific, Johnson & Johnson, PwC, and BCG.\n\"We are excited that these directors will bring a wealth of experience to Envoy as we become a publicly traded company and disrupt the hearing implant industry with our fully implanted cochlear implant,\" stated Brent Lucas, Chief Executive Officer of Envoy. \"We believe these individuals will provide excellent guidance, tremendous knowledge, and diligent governance to help drive business success and shareholder value. We have benefitted from a tremendous private board to help us get to this point, and we believe the new public board will carry that momentum forward.\"\n\"A world-class board is a key part of our planned merger with Envoy, providing additional experience, resources and connections to support its mission in hearing health,\" said Dr. Whitney Haring-Smith, Chairman of Anzu, with which Envoy intends to merge in a transaction expected to close in September 2023 (the \"Proposed Business Combination\"). Hereinafter the merged entity is referred to as \"New Envoy\".\nThe nominees to serve on New Envoy's Board of Directors (the \"New Envoy Board\") upon the closing of the Proposed Business Combination are:\nCharles (Chuck) Brynelsen\nMr. Brynelsen is expected to serve as the chairman of the New Envoy Board upon closing of the merger with Anzu. Mr. Brynelsen has extensive experience in the medical device industry, including most recently serving as Senior Vice President and President of Abbott Vascular from 2017 to 2021. Since 2015 he has also been a Venture Partner of SpringRock Ventures, an investment firm that focuses on digital health, devices, services, oral health, SAAS, consumerization/ecommerce of healthcare, IT and wellness. Mr. Brynelsen...